ResMed Inc. (RMD)
After hours:
| Previous close | 240.69 |
| Open | 241.79 |
| Bid | 0.00 x 1300 |
| Ask | 241.62 x 900 |
| Day's range | 241.12 - 246.12 |
| 52-week range | 179.37 - 301.34 |
| Volume | |
| Avg. volume | 499,934 |
| Market cap | 35.176B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 70.75 |
| EPS (TTM) | 3.41 |
| Earnings date | 27 Jan 2022 |
| Forward dividend & yield | 1.68 (0.70%) |
| Ex-dividend date | 09 Nov 2021 |
| 1y target est | 276.50 |
- Zacks
Down 9.2% in 4 Weeks, Here's Why You Should You Buy the Dip in ResMed (RMD)
The heavy selling pressure might have exhausted for ResMed (RMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- GlobeNewswire
ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on Thursday, January 27, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details: •Location:http://investor.resmed.com•
- GlobeNewswire
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, beginning at approximately 1:30 p.m. (Eastern Standard Time) via webcast. More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. Conference attendees will be able to access the video webcas
